Trial Profile
Planned phase II trial of CMX 157 in patients with HIV infections.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2019
Price :
$35
*
At a glance
- Drugs Tenofovir exalidex (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 23 Jan 2015 New trial record